Arthroscopic stem cell cartilage transplant, also known as autologous chondrocyte implantation (ACI), is a surgical procedure used to repair articular cartilage defects in the knee joint. It involves harvesting healthy cartilage cells from a patient’s own knee, which are then grown and multiplied in a laboratory before being re-implanted into the damaged area of the joint.
The aim of the procedure is to provide a new, healthy layer of cartilage that can help restore normal joint function and reduce pain and stiffness associated with cartilage damage. It is typically performed in patients who have experienced significant knee cartilage damage due to injury or osteoarthritis, and who have not responded well to non-surgical treatments such as physical therapy or medication.
The rehabilitation process for an arthroscopic stem cell cartilage transplant typically involves a gradual progression of exercises and activities designed to promote healing, restore strength and mobility, and protect the newly transplanted cartilage. The specific rehabilitation plan will vary depending on the patient’s individual needs and the extent of the damage to the knee joint.
Arthroscopic stem cell cartilage transplant is a minimally invasive surgical procedure that uses stem cells to replace damaged cartilage in joints. The procedure involves harvesting healthy stem cells from the patient’s own body and using them to stimulate the growth of new cartilage tissue in the affected joint. This technique has been found to be particularly effective in treating knee injuries and arthritis, but it can also be used in other joints such as the hip, ankle, and shoulder. The goal of this procedure is to restore function and alleviate pain in the affected joint, as well as to prevent further degeneration of the joint.